| | Advanced Search

 

Leonardo Angiulo: Further Refining the Investigation of Marijuana Offenses—Leonardo Angiulo: Further Refining the Investigation of Marijuana…

Smart Benefits: 2015 Health Insurance Rates Approved—Rhode Island’s Health Insurance Commissioner recently announced approved…

Basketball Recruiting: MA, RI Players With D1 Futures- Class of 2015—Basketball Recruiting: MA, RI Players With D1 Futures-…

College Admissions: 6 Tips for Adjusting to College Life—How to make the transition fun and easier

Training Camp Talk: Stocks Rising & Falling—The Patriots have completed four full days of…

Revs Topped By Late Crew Goal, Drop 8th Straight—An 84th minute goal by Ethan Finlay of…

20 Things Most Worcester Natives Have Experienced—What makes Worcester unique? It is the places,…

Fit for Life: Want to Lose Weight? Ready, Set, GO!—There really are only 3 ways to lose…

MA Beauty Insider: Nautical Chic - The Breton T-shirt—Striped cabanas and awnings have always been evocative…

Clark University Study Finds LGB Parents and Their Children Functioning Well—Clark University Study Finds LGB Parents and Their…

 
 

AG Announces $68.5 Million Settlement with AstraZeneca

Friday, March 11, 2011

 

Attorney General Peter Kilmartin announced today that a $68.5 million dollar settlement has been reached with AstraZeneca Pharmaceuticals.

This settlement, which is the largest ever multi-state consumer protection-based pharmaceutical settlement, is expected to bring $908,838 to the state.

The settlement stems from a complaint alleging that AstraZeneca used deceptive practices to market the antipsychotic drug Seroquel for off-label uses, according to the Attorney General. The company was accused of withholding information on the drug’s dangerous potential side effects, in addition to the negative results of scientific study done that tested the safety of the drug.

“This settlement shows the commitment of this office to protect consumers from deceptive marketing and advertising practices by big pharmaceutical companies,” Kilmartin said.

Company promises changes

AstraZeneca has promised to alter the way that it markets Seroquel, eliminating the misleading practices in question. Along with the $68.5 million payment, under the settlement AstraZeneca must comply with provisions addressing numerous concerns that an extensive 3-year investigation yielded. For example, AstraZeneca must have policies in place to ensure that sales personnel do not promote to health care providers who are unlikely to prescribe Seroquel for an FDA-approved use.

Other states participating in the investigation and settlement were: Florida, Illinois, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Washington, West Virginia and Wisconsin.
 

 

Enjoy this post? Share it with others.

You Must be Logged In to Comment

Tracker Pixel for Entry